{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:32:30Z","timestamp":1784759550204,"version":"3.55.0"},"reference-count":78,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Interleukin (IL)-37 and IL-33 are among the latest cytokines identified, playing a role in several inflammatory conditions, spanning from systemic conditions to tumors to localized diseases. As newly discovered interleukins, their role is still scarcely understood, but their potential role as therapeutic targets or disease activity markers suggests the need to reorganize the current data for a better interpretation. The aim of this review is to collect and organize data produced by several studies to create a complete picture. The research was conducted on the PubMed database, and the resulting articles were sorted by title, abstract, English language, and content. Several studies have been assessed, mostly related to atopic dermatitis and immunologic pathways. Collective data demonstrates a pro-inflammatory role of IL-33 and an anti-inflammatory one for IL-37, possibly related to each other in an IL-33\/IL-37 axis. Although further studies are needed to assess the safety and plausibility of targeting these two interleukins for patients affected by skin conditions, the early results indicate that both IL-33 and IL-37 represent markers of disease activity.<\/jats:p>","DOI":"10.3390\/ijms24010372","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T04:42:47Z","timestamp":1672116167000},"page":"372","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-8441","authenticated-orcid":false,"given":"Francesco","family":"Borgia","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2142-5054","authenticated-orcid":false,"given":"Paolo","family":"Custurone","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-9468","authenticated-orcid":false,"given":"Federica","family":"Li Pomi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-5145","authenticated-orcid":false,"given":"Mario","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Alessandrello","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3389\/fimmu.2022.951535","article-title":"Pathogenic Roles and Diagnostic Utility of Interleukin-18 in Autoinflammatory Diseases","volume":"13","author":"Shimizu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rozario, C., Mart\u00ednez-Sobrido, L., McSorley, H.J., and Chauch\u00e9, C. (2021). Could Interleukin-33 (IL-33) Govern the Outcome of an Equine Influenza Virus Infection? Learning from Other Species. Viruses, 13.","DOI":"10.3390\/v13122519"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1007\/s12325-022-02241-y","article-title":"The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases","volume":"39","author":"Turchin","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, Inflammation, and Pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Li Pomi, F., Borgia, F., Custurone, P., Vaccaro, M., Pioggia, G., and Gangemi, S. (2022). Role of HMGB1 in Cutaneous Melanoma: State of the Art. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169327"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vaccaro, M., Irrera, N., Cutroneo, G., Rizzo, G., Vaccaro, F., Anastasi, G., Borgia, F., Cannav\u00f2, S., Altavilla, D., and Squadrito, F. (2017). Differential Expression of Nitric Oxide Synthase Isoforms NNOS and INOS in Patients with Non-Segmental Generalized Vitiligo. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122533"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"952231","DOI":"10.3389\/fimmu.2022.952231","article-title":"IL12 Immune Therapy Clinical Trial Review: Novel Strategies for Avoiding CRS-Associated Cytokines","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e14660","DOI":"10.1111\/dth.14660","article-title":"New Generation Biologics for the Treatment of Psoriasis and Psoriatic Arthritis. State of the Art and Considerations about the Risk of Infection","volume":"34","author":"Ceccarelli","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Furue, M. (2020). Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13\/IL-4-JAK-STAT6\/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113741"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Murdaca, G., Greco, M., Tonacci, A., Negrini, S., Borro, M., Puppo, F., and Gangemi, S. (2019). IL-33\/IL-31 Axis in Immune-Mediated and Allergic Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235856"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40618-018-0903-3","article-title":"Increased Serum Interleukin-37 (IL-37) Levels Correlate with Oxidative Stress Parameters in Hashimoto\u2019s Thyroiditis","volume":"42","author":"Ruggeri","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"808012","DOI":"10.3389\/fimmu.2021.808012","article-title":"The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier","volume":"12","author":"Macleod","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03191127","article-title":"Pharmacokinetics of IL-18 Binding Protein in Healthy Volunteers and Subjects with Rheumatoid Arthritis or Plaque Psoriasis","volume":"31","author":"Tak","year":"2006","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/geno.2002.6752","article-title":"Genomic Organization of the Interleukin-1 Locus","volume":"79","author":"Taylor","year":"2002","journal-title":"Genomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.180.8.5477","article-title":"The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines","volume":"180","author":"Sharma","year":"2008","journal-title":"J. Immunol."},{"key":"ref_16","first-page":"263","article-title":"Mast Cell, pro-Inflammatory and Anti-Inflammatory: Jekyll and Hyde, the Story Continues","volume":"31","author":"Conti","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00403-016-1675-2","article-title":"IL-33 Circulating Serum Levels Are Increased in Patients with Non-Segmental Generalized Vitiligo","volume":"308","author":"Vaccaro","year":"2016","journal-title":"Arch. Dermatol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-60761-869-0_15","article-title":"Antiinflammatory and immunosuppressive functions of mast cells","volume":"677","author":"Kalesnikoff","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2013.00181","article-title":"Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease","volume":"4","author":"Lopetuso","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jim.2012.10.017","article-title":"Analysis of Nuclear Localization of Interleukin-1 Family Cytokines by Flow Cytometry","volume":"387","author":"Ross","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular Forms of IL-37 Inhibit Innate Inflammation in Vitro and in Vivo but Require the IL-1 Family Decoy Receptor IL-1R8","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1160\/TH15-12-0917","article-title":"Interleukin-33 Stimulates GM-CSF and M-CSF Production by Human Endothelial Cells","volume":"116","author":"Montanari","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_23","first-page":"329","article-title":"Correlation of Serum Levels of IL-33, IL-37, Soluble Form of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), and Circulatory Frequency of VEGFR2-Expressing Cells with Multiple Sclerosis Severity","volume":"16","author":"Kouchaki","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/mmy\/myx050","article-title":"Differential Production of Interleukin-1 Family Cytokines (IL-1\u03b2, IL-18, IL-33 and IL-37) in Patients with Paracoccidioidomycosis: Correlation with Clinical Form and Antifungal Therapy","volume":"56","author":"Alves","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1073\/pnas.1821111116","article-title":"Role for Nuclear Interleukin-37 in the Suppression of Innate Immunity","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00011-022-01596-w","article-title":"The Role of IL-1 Family of Cytokines and Receptors in Pathogenesis of COVID-19","volume":"71","author":"Makaremi","year":"2022","journal-title":"Inflamm. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.21037\/atm-20-4729","article-title":"Interleukin (IL)-1 Family Cytokines Could Differentiate Primary Immune Thrombocytopenia from Systemic Lupus Erythematosus-Associated Thrombocytopenia","volume":"9","author":"Zhan","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2018.03.016","article-title":"Elevated Expression of TSLP and IL-33 in Beh\u00e7et\u2019s Disease Skin Lesions: IL-37 Alleviate Inflammatory Effect of TSLP","volume":"192","author":"Kacem","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_29","first-page":"179","article-title":"Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris","volume":"17","author":"Sehat","year":"2018","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_30","first-page":"1061","article-title":"IL-33 Mediates Allergy through Mast Cell Activation: Potential Inhibitory Effect of Certain Cytokines","volume":"32","author":"Tettamanti","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_31","first-page":"1981","article-title":"CAR-T Cell Therapy Causes Inflammation by IL-1 Which Activates Inflammatory Cytokine Mast Cells: Anti-Inflammatory Role of IL-37","volume":"33","author":"Caraffa","year":"2019","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children with Early-Onset Atopic Dermatitis","volume":"155","author":"Diaz","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2020.00752","article-title":"IL-37 Ameliorating Allergic Inflammation in Atopic Dermatitis Through Regulating Microbiota and AMPK-MTOR Signaling Pathway-Modulated Autophagy Mechanism","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"745997","DOI":"10.3389\/fimmu.2022.745997","article-title":"Natural Compounds Tapinarof and Galactomyces Ferment Filtrate Downregulate IL-33 Expression via the AHR\/IL-37 Axis in Human Keratinocytes","volume":"13","author":"Tsuji","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.imlet.2016.08.004","article-title":"Increased Expression of Thymic Stromal Lymphopoietin in Induced Sputum from Asthmatic Children","volume":"178","author":"Hamdi","year":"2016","journal-title":"Immunol. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106476","DOI":"10.1016\/j.intimp.2020.106476","article-title":"IL-37 Is Protective in Allergic Contact Dermatitis through Mast Cell Inhibition","volume":"83","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/all.15072","article-title":"IL-37 Regulates Allergic Inflammation by Counterbalancing Pro-inflammatory IL-1 and IL-33","volume":"77","author":"Lunding","year":"2022","journal-title":"Allergy"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Borgia, F., Custurone, P., Li Pomi, F., Cordiano, R., Alessandrello, C., and Gangemi, S. (2022). IL-31: State of the Art for an Inflammation-Oriented Interleukin. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126507"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rai, V., Dilisio, M.F., Samadi, F., and Agrawal, D.K. (2022). Counteractive Effects of IL-33 and IL-37 on Inflammation in Osteoarthritis. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095690"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2022.11.006","article-title":"IL-33-ILC2 Axis Promotes Anti-Tumor CD8+ T Cell Responses via OX40 Signaling","volume":"637","author":"Okuyama","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109493","DOI":"10.1016\/j.intimp.2022.109493","article-title":"Contribution of IL-33\/ILC2-Mediated Th2 Cytokines during the Progression of Minimal Change Disease","volume":"114","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Szczepanik-Ku\u0142ak, P., Michalska-Jakubus, M., Kowal, M., and Krasowska, D. (2022). Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216375"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e13191","DOI":"10.1111\/dth.13191","article-title":"Impact of Mast Cells in Fibromyalgia and Low-grade Chronic Inflammation: Can IL-37 Play a Role?","volume":"33","author":"Conti","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cyto.2017.10.016","article-title":"IL-37 and Leprosy: A Novel Cytokine Involved in the Host Response to Mycobacterium leprae Infection","volume":"106","author":"Prudente","year":"2018","journal-title":"Cytokine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13075-018-1555-6","article-title":"Interleukin-37 Is Increased in Adult-Onset Still\u2019s Disease and Associated with Disease Activity","volume":"20","author":"Chi","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109705","DOI":"10.1016\/j.biopha.2019.109705","article-title":"The Role of IL-37 in Skin and Connective Tissue Diseases","volume":"122","author":"Pan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Boutet, M.-A., Nerviani, A., and Pitzalis, C. (2019). IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061257"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4049\/immunohorizons.2100055","article-title":"Transcriptomic Analysis of Healthy and Atopic Dermatitis Samples Reveals the Role of IL-37 in Human Skin","volume":"5","author":"Zhou","year":"2021","journal-title":"Immunohorizons"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4049\/jimmunol.1801515","article-title":"IL-37 Attenuates Lung Fibrosis by Inducing Autophagy and Regulating TGF-\u03921 Production in Mice","volume":"203","author":"Kim","year":"2019","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2005.10.004","article-title":"An IL-1 Family Member Requires Caspase-1 Processing and Signals through the ST2 Receptor","volume":"23","author":"Dinarello","year":"2005","journal-title":"Immunity"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e20212397","DOI":"10.1084\/jem.20212397","article-title":"A Dysregulated Sebum\u2013Microbial Metabolite\u2013IL-33 Axis Initiates Skin Inflammation in Atopic Dermatitis","volume":"219","author":"Qiu","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/exd.14217","article-title":"Early Transcriptional Changes after UVB Treatment in Atopic Dermatitis Include Inverse Regulation of IL-36\u03b3 and IL-37","volume":"30","author":"Lossius","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4049\/immunohorizons.2000083","article-title":"IL-37 Expression Is Downregulated in Lesional Psoriasis Skin","volume":"4","author":"Nielsen","year":"2020","journal-title":"Immunohorizons"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e12943","DOI":"10.1111\/dth.12943","article-title":"Activation of Mast Cells Mediates Inflammatory Response in Psoriasis: Potential New Therapeutic Approach with IL-37","volume":"32","author":"Conti","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_55","first-page":"6492","article-title":"Establishment and Validation of Evaluation Models for Post-Inflammatory Pigmentation Abnormalities","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Conti, P., Pregliasco, F.E., Bellomo, R.G., Gallenga, C.E., Caraffa, A., Kritas, S.K., Lauritano, D., and Ronconi, G. (2021). Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158076"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ol.2022.13278","article-title":"Excessive Activation of IL-33\/ST2 in Cancer-associated Fibroblasts Promotes Invasion and Metastasis in Ovarian Cancer","volume":"23","author":"Feng","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"981479","DOI":"10.3389\/fimmu.2022.981479","article-title":"Emerging Roles for IL-25 and IL-33 in Colorectal Cancer Tumorigenesis","volume":"13","author":"Jou","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"154023","DOI":"10.1016\/j.prp.2022.154023","article-title":"Increased Expression of ST2 on Regulatory T Cells Is Associated with Cancer Associated Fibroblast-Derived IL-33 in Laryngeal Cancer","volume":"237","author":"Zhao","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1177\/15353702221102094","article-title":"The Role of IL-33\/ST2 Signaling in the Tumor Microenvironment and Treg Immunotherapy","volume":"247","author":"Lei","year":"2022","journal-title":"Exp. Biol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the Alarmin IL-33 Regulates ST2-Dependent Inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41598-018-21589-2","article-title":"Interleukin-33 Is Activated by Allergen- and Necrosis-Associated Proteolytic Activities to Regulate Its Alarmin Activity during Epithelial Damage","volume":"8","author":"Scott","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdermsci.2022.07.009","article-title":"IL-33\/ST2 Axis Contributes to the Dermal Fibrosis of Systemic Sclerosis via Promoting Fibroblasts Activation","volume":"107","author":"Wu","year":"2022","journal-title":"J. Dermatol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2020.02.018","article-title":"Efficacy and Tolerability of Intralesional Bleomycin in Dermatology: A Systematic Review","volume":"83","author":"Bik","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/1346-8138.14334","article-title":"Interleukin-33 Is Expressed in the Lesional Epidermis in Herpes Virus Infection but Not in Verruca vulgaris","volume":"45","author":"Jin","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"101819","DOI":"10.1016\/j.pdpdt.2020.101819","article-title":"Efficacy and Safety of Conventional versus Daylight Photodynamic Therapy in Children Affected by Multiple Facial Flat Warts","volume":"31","author":"Borgia","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Rasheed, K., Moens, U., Policastro, B., Johnsen, J.I., Koljonen, V., Sihto, H., Lui, W.-O., and Sveinbj\u00f8rnsson, B. (2022). The Merkel Cell Polyomavirus T-Antigens and IL-33\/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073702"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00403-018-1807-y","article-title":"Phenotyping Acute and Chronic Atopic Dermatitis-like Lesions in Stat6VT Mice Identifies a Role for IL-33 in Disease Pathogenesis","volume":"310","author":"Thyagarajan","year":"2018","journal-title":"Arch. Dermatol. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"155935","DOI":"10.1016\/j.cyto.2022.155935","article-title":"IL-1 Family Cytokines Serve as \u201cActivity Recognition Receptors\u201d for Aberrant Protease Activity Indicative of Danger","volume":"157","author":"Martin","year":"2022","journal-title":"Cytokine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10103-021-03328-8","article-title":"MMP-3 Plays a Major Role in Calcium Pantothenate-Promoted Wound Healing after Fractional Ablative Laser Treatment","volume":"37","author":"Huth","year":"2022","journal-title":"Lasers Med. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"106719","DOI":"10.1016\/j.intimp.2020.106719","article-title":"Therapeutic Effects of Interleukin-37 and Induced Cardiosphere on Treating Myocardial Ischemia-Reperfusion Injury","volume":"88","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1479-5876-12-69","article-title":"IL-37 Inhibits the Production of Inflammatory Cytokines in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Its Correlation with Disease Activity","volume":"12","author":"Ye","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.55133\/eji.290414","article-title":"Serum Interleukin-33 (IL-33) in Children with Active Systemic Lupus Erythematosus: A Cross-Sectional Study","volume":"29","author":"Abdelnabi","year":"2022","journal-title":"Egypt. J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/0961203316646462","article-title":"Elevated Plasma Interleukin-37 Levels in Systemic Lupus Erythematosus Patients","volume":"25","author":"Wu","year":"2016","journal-title":"Lupus"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"156015","DOI":"10.1016\/j.cyto.2022.156015","article-title":"IL-33\/ST2 Axis in Autoimmune Disease","volume":"158","author":"Shakerian","year":"2022","journal-title":"Cytokine"},{"key":"ref_76","first-page":"299","article-title":"Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet\u2019s Disease","volume":"16","author":"Hamzaoui","year":"2019","journal-title":"Iran. J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1566524014666140414210831","article-title":"A Possible Role for Interleukin 37 in the Pathogenesis of Behcet\u2019s Disease","volume":"14","author":"Ye","year":"2014","journal-title":"Curr. Mol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.imlet.2015.08.001","article-title":"Interleukin-37 Expression Is Decreased in Beh\u00e7et\u2019s Disease and Is Associated with Inflammation","volume":"167","author":"Bouali","year":"2015","journal-title":"Immunol. Lett."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/372\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:51:34Z","timestamp":1760147494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010372"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010372","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]}}}